Abstract
Hematologic malignancies are a large and heterogeneous group of neoplasms characterized by complex pathogenetic mechanisms. The abnormal regulation of epigenetic mechanisms and specifically, histone modifications, has been demonstrated to play a central role in hematological cancer pathogenesis and progression. A variety of epigenetic enzymes that affect the state of histones have been detected as deregulated, being either over- or underexpressed, which induces changes in chromatin compaction and, subsequently, affects gene expression. Recent advances in the field of epigenetics have revealed novel therapeutic targets, with many epigenetic drugs being investigated in clinical trials. The present review focuses on the biological impact of histone modifications in the pathogenesis of hematologic malignancies, describing a wide range of therapeutic agents that have been discovered to target these alterations and are currently under investigation in clinical trials.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference252 articles.
1. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., and Stein, H.T.J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2016.
2. Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network;Smith;Br. J. Cancer,2011
3. Epigenetic modifications: Basic mechanisms and role in cardiovascular disease;Handy;Circulation,2011
4. Histone modifications and their role in epigenetics of atopy and allergic diseases;Alaskhar Alhamwe;Allergy Asthma Clin. Immunol.,2018
5. Histone N-alpha terminal modifications: Genome regulation at the tip of the tail;Demetriadou;Epigenetics Chromatin,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献